Swine-Origin Probiotic Strains for Weaning Gut Stability
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The swine industry faces challenges with gastrointestinal instability and increased susceptibility to infectious diseases during weaning due to dietary shifts, leading to gut microbiome dysbiosis and reduced growth performance, necessitating alternative solutions to antibiotics.
Innovation Solution
Administration of probiotic compositions comprising isolated bacterial strains, such as Lactobacillus strain LactX and Streptococcus strain StrepX3, to modulate the gut microbiome and enhance growth performance in pigs.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If antibiotics are fed to nursery pigs to prevent colonization by pathogenic microorganisms, then growth performance is improved, but antibiotic resistance develops and public health concerns increase
Solution Approach 1:
The patent uses probiotic bacteria (Lactobacillus and Streptococcus strains) as intermediary organisms that colonize the gut and prevent pathogenic bacteria from establishing themselves. These probiotics act as mediators between the host pig and the pathogenic microorganisms, providing protective effects without using antibiotics. The probiotics compete for nutrients and attachment sites, produce antimicrobial substances, and modulate the immune system to prevent pathogen colonization.
Solution Approach 2:
The patent changes the microbial composition parameter of the gut ecosystem by introducing specific probiotic strains. This shifts the balance from a pathogen-dominated microbiome to a probiotic-dominated one, fundamentally altering the biological environment to prevent disease without antibiotics. The parameter change involves transforming the gut microbiome structure to favor beneficial bacteria that outcompete pathogens.
2Reliability
If probiotics are used to modulate the gut microbiome, then pathogen entry is prevented and beneficial bacteria residency is promoted, but inconsistent results are reported in studies investigating growth performance improvement
Solution Approach 1:
The patent segments the probiotic approach by using specific, isolated bacterial strains (Lactobacillus and Streptococcus) rather than mixed cultures or undefined probiotic formulations. Each strain is individually characterized and tested for its specific effects on growth performance. This segmentation allows for precise identification of which strains provide beneficial effects and under what conditions, resolving the inconsistency seen in broader probiotic studies.
Solution Approach 2:
The patent applies partial action by focusing on specific growth stages (nursery and growing phases) rather than attempting to improve performance across all life stages. The probiotic intervention is targeted at critical periods when pigs are most vulnerable to pathogen colonization and when gut microbiome establishment is most influential on future performance. This targeted approach explains and standardizes the growth performance improvements.
3Quantity of substance
If drastic dietary shifts are made from pre-weaning milk diet to corn-soybean meal based diet, then nutritional requirements are met for growth, but gastrointestinal instability and immune instability occur
Solution Approach 1:
The patent applies preliminary action by introducing probiotic bacteria before and during the dietary transition at weaning. The probiotics are administered in advance to establish a stable microbial population that can handle the dietary change. This pre-established microbial community helps digest the new complex carbohydrates in the corn-soybean diet, produces beneficial metabolites, and maintains gut barrier function during the transition, preventing gastrointestinal and immune instability.
Solution Approach 2:
The probiotic bacteria serve as intermediaries between the pig's digestive system and the complex carbohydrates in the new diet. These bacteria produce enzymes that break down difficult-to-digest components, generate short-chain fatty acids that nourish gut cells, and maintain intestinal barrier integrity. This intermediary microbial action facilitates the dietary transition while maintaining gastrointestinal stability.
Data Source
AI summary
The present invention provides probiotic compositions comprising isolated bacterial strains, referred to herein as LactX, StrepX1 and StrepX3. Methods of using the compositions to increase growth rate in pigs and enhance pig production are also provided.


